United States Non-alcoholic Steatohepatitis Therapeutic &...

added blog Other

2026-06-30 14:03:32

United States Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market Poised for Growth Through Next-Generation Therapies

The United States holds a leading position in the Non-alcoholic Steatohepatitis Therapeutic & Diagnostic Market, driven by the high prevalence of obesity, type 2 diabetes, and metabolic syndrome, which are major risk factors for liver disease. The country benefits from a strong healthcare infrastructure, significant investments in liver disease research, and the presence of leading...

0 Comments 0 Shares 48 Views 0 Reviews